The AI-powered drug discovery platform received commitments from Echo Health Ventures, Amgen Ventures, Alexandria Venture Investments and Celgene in the Cigna-led round.
US-based precision medicine platform operator GNS Healthcare received $23m on Tuesday in a series D round led by Cigna Ventures, the corporate venturing arm of healthcare provider Cigna.
Echo Health Ventures, which was formed by hospital manager Cambia Health Solutions with health insurer Blue Cross Blue Shield of North Carolina’s Mosaic Health Solutions vehicle, also took part in the round.
Pharmaceutical firms Celgene and Amgen, through its corporate venture capital subsidiary Amgen Ventures, filled out the round together with Alexandria…
